Search Results
Jul 14, 2026, 14:28 ET As AI Agents Scale, Enterprises Demand Execution Control -- Devenex Takes Control
scaling enterprise AI, ahead of model quality or talent. Deloitte's 2026 enterprise survey finds that 80 percent of leaders piloting AI agents cite security and compliance as the leading obstacle — up from 68 percent a year earlier.The pattern is consistent across every credible source: enterprises
More news about: DEVENEX
Jul 14, 2026, 11:53 ET MNA: Baystate Franklin Nurses Cite Safety Risks in DPH Complaint Over Cuts to Patient Transport Services, Will Hold Press Conference July 16
multimedia:https://www.prnewswire.com/news-releases/mna-baystate-franklin-nurses-cite-safety-risks-in-dph-complaint-over-cuts-to-patient-transport-services-will-hold-press-conference-july-16-302825344.htmlSOURCE
More news about: Massachusetts Nurses Association
Jul 14, 2026, 11:00 ET Ford Philanthropy, Uber, and Rocket Community Fund Join Last Mile Education Fund to Keep Thousands of STEM Students on the Road to Graduation
Thirty-five percent of Last Mile students cite transportation and mobility challenges as a barrier to persistence. Across the country, transportation disruptions—from unexpected car repairs to limited
More news about: Last Mile Education Fund
Jul 14, 2026, 10:00 ET First 5W Study of Grocery-Brand AI Visibility: Trader Joe's Beats Cheerios, Kirkland Beats Heinz
Grocery edition of The Private Label AI Advantage, and the opening installment of a five-part 5W research series measuring how answer engines cite store brands against national brands across grocery, e-commerce, pet, pharmacy, and supplements.
More news about: 5W Public Relations
Jul 14, 2026, 09:00 ET Mid-Year Survey: 42% of Americans Have Skipped or Delayed Medical Care in the Past Year Due to Inflation
42% of Medicare beneficiaries identified at least one point of dissatisfaction with their current coverage; 18% cite high monthly premiums for their Medicare plan, while 14% cite high out-of-pocket costs.33% of Medicare beneficiaries say their healthcare costs are higher than they expected
More news about: eHealth, Inc.
Jul 14, 2026, 09:00 ET myTomorrows Survey Reveals 52% of Clinical Trial Sites Say 1 in 5 Referrals Are Ineligible Before Screening Even Begins
quality.Sites are managing too many systems. 52% use at least four tools for pre-screening alone and 43% use four or more for referral intake, while 42% cite delays in accessing complete patient information as a top barrier — friction at exactly the point where speed and accuracy matter most.The
More news about: myTomorrows
Jul 14, 2026, 09:00 ET AI redesigns jobs, not cuts them: JLL study reveals business leaders expect workforce growth ahead
(24%).This renewed focus appears to shift the CRE function's attention away from cost optimization toward capability enablement, yet leaders simultaneously cite the costs of executing these preferences as top concerns: AI-driven workforce automation (39%), technology infrastructure requirements (32%) and energy
More news about: JLL
Jul 14, 2026, 08:46 ET New Supermetrics Report Reveals Why Marketing's AI Readiness Still Falls Short
teams and 34% of enterprise marketing teams cite a lack of system integration between analytics tools and activation platforms as the biggest blocker between identifying an insight and acting on it. Another 20% of SMB teams and 27% of enterprise teams cite time-consuming manual data handoffs.Data
More news about: Supermetrics
Jul 13, 2026, 15:03 ET 97% of commercial software runs MIT-licensed open source, removing dev tool barriers, DHTMLX finds
53% of organizations cite zero license cost as the top reason for adopting open source software, according to the 2025 State of Open Source Report.WARSAW, Poland, July 13, 2026 /PRNewswire/ -- The
More news about: DHTMLX Gantt Community Edition
Jul 13, 2026, 11:41 ET Le camp d'été 2026 du « Yinghua Fellowship » s'est achevé avec succès
la cuisine cantonaise à la fabrication d'parapluies en papier huilé, en passant par une balade en bateau sur le lac de l'Ouest et la découverte de la Cité interdite — ont montré que la culture est une pratique vivante, et non une exposition statique. Ce consensus sur la synergie entre la technologie et
More news about: Guoqiang Public Welfare Foundation
Jul 13, 2026, 09:04 ET Status Labs Releases 2026 Edition of AI Reputation Management White Paper as ChatGPT Hits 2.5B Daily Queries
citation-pattern analyses across ChatGPT, Google AI Overviews, Claude, and Perplexity.A central finding concerns how AI systems choose what to cite. The report notes that AI search systems show a systematic bias toward earned media, meaning third-party authoritative coverage, over content a brand
More news about: Status Labs
Jul 13, 2026, 07:23 ET Cynosure Lutronic lance en Europe la technologie RF monopolaire de nouvelle génération, alors que la demande des patients pour le raffermissement cutané non invasif atteint des sommets sans précédent
elles préféraient les traitements ne nécessitant pas d'aiguilles. De même, la « preuve évidente de résultats durables » était le facteur le plus souvent cité pour inciter les patients indécis à envisager un traitement de raffermissement cutané non chirurgical : 28,3 % des personnes interrogées l'ont mentionné.Nikhil
More news about: Cynosure Lutronic
Jul 13, 2026, 06:40 ET Surviving Summer in the City: New Yorkers Are Turning to Underarm Laser to Beat Subway Sweat
compounding the discomfort that comes with a long, sweaty ride.Laser by Aleya notes that clients booking underarm treatments ahead of summer often cite the combination of heat, humidity, and crowded commuting conditions as their primary motivation, more so than a purely aesthetic preference. Reducing
More news about: Laser by Aleya
Jul 10, 2026, 07:03 ET Xinhua Silk Road : Le dialogue favorise l'apprentissage mutuel et les échanges entre les patrimoines culturels de Liangzhu et de Samarcande
10 juillet 2026 /PRNewswire/ -- Un événement de dialogue interculturel entre les vestiges archéologiques de la cité de Liangzhu à Hangzhou, dans la province du Zhejiang (Chine orientale), et la ville historique de Samarcande, en Ouzbékistan, s'est tenu le 6 juillet,
More news about: Xinhua Silk Road
Jul 09, 2026, 11:00 ET StrongSuit 2.0 Reimagines the Litigation Workflow with a Fully Connected AI Platform
ensuring strong case law coverage across each issue and sub-issue."Law is connected. The details of your evidence should inform the cases you cite, and both should shape how you argue in your drafts," said Justin McCallon, CEO of StrongSuit. "Our agentic matter portal and case law capabilities are
More news about: StrongSuit
Jul 09, 2026, 08:00 ET Two-Year College Built for Gen Z Launches Cybersecurity Program Designed for the AI Threat Landscape
ISC2 Cybersecurity Workforce Study, 95% of cybersecurity teams report at least one skills gap with professionals and cite skills deficits, not just headcount, as one of their most pressing challenges as AI rapidly reshapes both the nature of attacks and the expertise required
More news about: Campus.edu
Jul 09, 2026, 08:00 ET Rehab Therapists Will Lose Nearly Five Years of Their Careers to Documentation, New Ensora Health Research Finds
documentation, yet only 21% use it that way today, a 49-point gap between belief and adoption.More than half of rehab therapists (55%) cite distrust of clinical accuracy as the top barrier to AI adoption, followed by data privacy concerns (46%) and quality-of-care concerns (45%).32%
More news about: Ensora Health
Jul 08, 2026, 09:00 ET Onspring 2026 GRC Benchmarking Report Reveals That Only 13.5% of GRC Teams Have Fully Integrated AI Into Core Workflows
dictate AI expansion limits: The primary friction points slowing broader adoption are fundamentally rooted in security and accuracy. Practitioners cite data privacy concerns (28.6%) and output accuracy or hallucinations (25.4%) as the top boundaries limiting AI deployment.Manual
More news about: Onspring
Jul 08, 2026, 08:42 ET Employers Plan to Hire in Second Half of 2026, but Nearly Half Can't Fill Open Roles
needs, not optimism alone. Among companies planning to increase headcount, the top reasons are practical business needs:53% cite increased volumes of work.49% say they are filling newly created positions.42% are replacing positions open due to employee turnover.37%
More news about: Express Services dba Express Employment Professionals
Jul 08, 2026, 08:07 ET 94% of Employers Ready to Add Prescription Savings Tools Amid Rising Drug Costs
Surprises Act, and SOC 2 certification were 90% likely to adopt a solution — compared to 63% among those who were not. While employers and brokers both cite compliance as a key trust lever, brokers showed more hesitation overall, suggesting that ROI documentation alongside compliance materials may be important
More news about: Buzz Health
Jul 07, 2026, 13:15 ET Forbes Beat The New York Times Inside AI: 5W Research
New 5W Index scores the 50 biggest U.S. publications on how often AI answer engines actually cite them. Forbes leads at 98. Reuters second at 91. The New York Times third at 88. Fast Company scores 36. The prestige hierarchy just re-ranked — and paywalls are the reason.
More news about: 5W Public Relations
Jul 07, 2026, 09:00 ET 68% of Americans Want to 'Earn' Their Way Out of Phone Bill, Survey Finds
switching decisions51% say lower monthly cost is the single biggest factor driving a mobile provider switch.38% cite network reliability as their top concern about switching to a nontraditional provider, followed by data privacy (36%) and hidden fees (27%).26%
More news about: Circles
Jul 07, 2026, 08:30 ET New Research: Why Enterprise Agentic AI Stalls Before It Scales
challenging to unify data and knowledge across business functions so agents can reason across the full enterprise.The top two barriers leaders cite — data lacking the necessary metadata, context, and relationships (43%) and data fragmented across systems that cannot be connected in real time
More news about: Teradata
Jul 06, 2026, 13:45 ET AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
have fewer treatment options each time the disease returns," said Catherine Thieblemont, M.D., Ph.D., head of the hemato-oncology department, Paris Cité University, Hôpital Saint-Louis Assistance-Publique-Hopitaux de Paris (APHP) in Paris. "The results shown in the EPCORE FL-1 trial are clinically meaningful,
More news about: AbbVie
Jul 06, 2026, 13:45 ET AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
have fewer treatment options each time the disease returns," said Catherine Thieblemont, M.D., Ph.D., head of the hemato-oncology department, Paris Cité University, Hôpital Saint-Louis Assistance-Publique-Hopitaux de Paris (APHP) in Paris. "The results shown in the EPCORE FL-1 trial are clinically meaningful,
More news about: AbbVie